Double maintains 2 strategies that include AGIO - Agios Pharmaceuticals, Inc.
Current Value
$32.351 Year Return
Current Value
$32.351 Year Return
Yahoo
CAMBRIDGE, Mass., March 05, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced the grant of inducement equity awards outside of the Company’s 2023 Stock Incentive Plan to its newly appointed Chief Corporate Development & Strategy Officer, Krishnan Viswanadhan. The grants were approved by the Board of Directors effective as of March 5, 2025, as inducements
Yahoo
CAMBRIDGE, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that its management team is scheduled to present at the following conferences: Leerink Global Healthcare Conference 2025: Fireside chat on Tuesday, March 11, 2025, at 10:50 a.m. ETBarclays 27th Annual Global Healthcare Conference: Fireside chat on Wednesday, March 12, 2025, at 12:30 p.m. ET The l
Yahoo
We recently published a list of the 10 Best Small-Cap Stocks to Buy Now. In this article, we are going to take a look at where Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) stands against the other small-cap stocks. The S&P 500 index has reached its all-time highs, achieving returns of over 20% for the second consecutive year […]
Yahoo
CAMBRIDGE, Mass., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that its management team is scheduled to present at the TD Cowen 45th Annual Healthcare Conference on Monday, March 3, 2025, at 10:30 a.m. ET. The live webcast will be accessible on the Investors section of the company's website (www.agios.com) under the “Events & Presentations” tab. A replay of t
Finnhub
CAMBRIDGE, Mass., Feb. 20, 2025 -- Agios Pharmaceuticals, Inc. , a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that its management team...
Yahoo
Scotiabank lowered the firm’s price target on Agios Pharmaceuticals (AGIO) to $74 from $75 and keeps an Outperform rating on the shares. The firm is impressed by the company’s regulatory and clinical execution in Q4, the analyst tells investors. Scotiabank believes Agios is well-equipped to accelerated growth of the Pyrukynd franchise and remains cautiously optimistic on mitapivat’s point of sickening. Published first on TheFly – the ultimate source for real-time, market-moving breaking financia
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TLRY | 0.02% | $608.07M | -66.74% | 0.00% |
HEES | 0.03% | $3.48B | +50.30% | 1.17% |
SOC | -0.04% | $2.32B | +132.11% | 0.00% |
PPC | -0.04% | $12.31B | +53.19% | 0.00% |
FDP | 0.07% | $1.43B | +18.82% | 3.52% |
PSQH | 0.08% | $116.30M | -44.12% | 0.00% |
ABT | -0.09% | $219.88B | +13.69% | 1.77% |
PG | 0.10% | $392.88B | +3.52% | 2.40% |
FINV | 0.10% | $1.46B | +100.20% | 2.41% |
PR | 0.10% | $9.83B | -19.20% | 4.04% |
HAL | 0.10% | $21.69B | -35.02% | 2.73% |
BPT | -0.10% | $12.41M | -75.73% | 0.00% |
UPLD | 0.11% | $94.08M | +19.29% | 0.00% |
DTE | -0.14% | $28.42B | +25.46% | 3.08% |
CALM | -0.14% | $4.35B | +43.47% | 4.85% |
TV | -0.15% | $762.17M | -41.10% | 0.00% |
IQ | -0.16% | $1.24B | -41.77% | 0.00% |
STZ | -0.16% | $32.32B | -33.59% | 2.27% |
UUU | 0.16% | $4.21M | +21.33% | 0.00% |
AGS | -0.17% | $500.88M | +34.89% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MOMO | -23.22% | $879.96M | +23.86% | 0.00% |
JKHY | -16.89% | $12.78B | +2.00% | 1.27% |
GIS | -14.88% | $32.14B | -15.20% | 4.10% |
TEM | -14.32% | $8.27B | 0.00% | 0.00% |
PAC | -14.15% | $8.25B | +26.29% | 0.00% |
SSL | -14.03% | $2.66B | -45.69% | 0.00% |
CME | -13.82% | $96.05B | +23.35% | 3.94% |
EQC | -13.29% | $171.87M | +23.14% | 0.00% |
HSY | -13.17% | $33.32B | -17.48% | 3.33% |
CBOE | -12.61% | $22.97B | +19.12% | 1.11% |
MKC | -12.42% | $21.64B | +16.15% | 2.13% |
BRY | -11.96% | $269.48M | -55.48% | 9.29% |
VZ | -11.90% | $184.17B | +7.92% | 6.13% |
GSK | -11.86% | $80.20B | -6.99% | 3.96% |
CPB | -11.41% | $11.32B | -12.18% | 3.93% |
ZCMD | -11.26% | $32.53M | -19.38% | 0.00% |
BP | -11.08% | $91.85B | -7.90% | 5.42% |
CVM | -11.08% | $20.96M | -85.63% | 0.00% |
CNC | -11.04% | $29.57B | -22.75% | 0.00% |
PRPH | -10.67% | $11.61M | -93.09% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CPRJ | 57.20% | $48.98M | 0.69% |
QQA | 51.58% | $167.69M | 0% |
RSPA | 49.37% | $280.76M | 0% |
CPSJ | 49.24% | $33.01M | 0.69% |
ETH | 48.25% | $1.29B | 0% |
CETH | 48.09% | $9.36M | 0% |
ETHA | 48.07% | $2.45B | 0.25% |
ETHV | 47.93% | $96.10M | 0% |
ETHW | 47.93% | $193.48M | 0% |
FETH | 47.92% | $812.30M | 0.25% |
QETH | 47.89% | $16.69M | 0.25% |
EZET | 47.67% | $23.96M | 0% |
XBI | 47.41% | $5.66B | 0.35% |
BTC | 45.27% | $3.28B | 0.15% |
XPH | 38.53% | $158.65M | 0.35% |
ARKG | 37.53% | $1.07B | 0.75% |
IBB | 36.82% | $6.06B | 0.45% |
IWO | 36.49% | $11.19B | 0.24% |
PBE | 36.45% | $240.72M | 0.58% |
ARKK | 36.40% | $5.43B | 0.75% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
INSM | 45.32% | $14.26B | +199.05% | 0.00% |
CORT | 42.38% | $6.08B | +132.69% | 0.00% |
ARCT | 38.12% | $348.22M | -61.24% | 0.00% |
COHR | 36.65% | $10.65B | +8.65% | 0.00% |
CRNX | 36.29% | $3.19B | -23.66% | 0.00% |
VTYX | 36.13% | $94.60M | -81.90% | 0.00% |
RVMD | 34.82% | $7.16B | +18.69% | 0.00% |
KROS | 34.77% | $464.03M | -83.43% | 0.00% |
RYTM | 34.35% | $3.43B | +33.44% | 0.00% |
DNLI | 34.32% | $2.12B | -30.43% | 0.00% |
HZO | 34.19% | $532.49M | -26.03% | 0.00% |
KYMR | 32.81% | $2.16B | -18.64% | 0.00% |
CRSP | 32.78% | $3.53B | -44.74% | 0.00% |
IDYA | 32.64% | $1.61B | -59.59% | 0.00% |
LGND | 32.58% | $2.11B | +49.96% | 0.00% |
KRYS | 31.97% | $5.43B | +11.08% | 0.00% |
LOVE | 31.83% | $270.54M | -23.22% | 0.00% |
TWST | 31.75% | $2.51B | +16.71% | 0.00% |
RCKT | 31.65% | $887.16M | -69.97% | 0.00% |
SYRE | 31.60% | $1.09B | -54.47% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
KWEB | -0.13% | $8.92B | 0.7% |
TFLO | 0.24% | $6.79B | 0.15% |
FTGC | 0.30% | $2.51B | 1.02% |
BCI | -0.31% | $1.35B | 0.26% |
USFR | -0.38% | $18.45B | 0.15% |
SOYB | -0.62% | $25.48M | 0.22% |
CQQQ | 0.70% | $1.16B | 0.65% |
IXC | 0.77% | $1.79B | 0.41% |
FXI | -0.83% | $8.24B | 0.74% |
ICLO | 0.85% | $355.46M | 0.2% |
TBLL | 0.88% | $2.05B | 0.08% |
CLOI | 0.95% | $997.25M | 0.4% |
CHIQ | -1.04% | $269.53M | 0.65% |
SHV | 1.07% | $19.68B | 0.15% |
FLOT | 1.15% | $8.91B | 0.15% |
JAAA | 1.17% | $21.90B | 0.21% |
PGJ | 1.21% | $171.13M | 0.67% |
YOLO | 1.23% | $24.87M | 1.03% |
KRBN | -1.26% | $180.36M | 0.85% |
MCHI | -1.33% | $6.78B | 0.59% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -28.58% | $392.24M | 1.43% |
VIXY | -23.33% | $195.31M | 0.85% |
TAIL | -16.70% | $83.83M | 0.59% |
DBE | -14.13% | $54.72M | 0.77% |
UGA | -13.17% | $85.26M | 0.97% |
BNO | -12.93% | $90.64M | 1% |
DBO | -12.93% | $190.57M | 0.77% |
USO | -12.54% | $891.33M | 0.6% |
UUP | -12.46% | $332.64M | 0.77% |
USL | -12.05% | $45.36M | 0.85% |
OILK | -11.16% | $64.75M | 0.69% |
CCOR | -9.68% | $63.91M | 1.18% |
GSG | -9.67% | $1.03B | 0.75% |
USDU | -9.12% | $214.47M | 0.5% |
COMT | -8.98% | $671.56M | 0.48% |
DBC | -7.72% | $1.33B | 0.87% |
TPMN | -7.72% | $33.27M | 0.65% |
PDBC | -7.14% | $4.85B | 0.59% |
KMLM | -6.32% | $227.79M | 0.9% |
VRIG | -6.16% | $1.33B | 0.3% |